Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis

• প্রধান লেখক: Rasoul Akbari (লেখক), Tahereh Behdarvand (লেখক), Reza Afarin (লেখক), Hamid Yaghooti (লেখক), Mohammad Taha Jalali (লেখক), Narges Mohammadtaghvaei (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2021-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have become significant global health concerns. In the present study, we aimed to investigate the effects of saroglitazar, a dual PPARα/γ agonist, fenofibrate, a PPAR-α agonist, and pioglitazone, a...